Site updated at Wednesday, 22 June 2016

Living with Dementia


Groups convince FDA to ease Alzheimer’s trial rules

Academic and industry experts said on Tuesday they have convinced U.S. regulators to ease safety restrictions imposed on clinical trials of Alzheimer’s drugs, a move that could improve the chances that a drug being developed jointly by Pfizer and Johnson & Johnson might succeed.

A 2008 study of 240 patients testing that drug, known… Groups convince FDA to ease Alzheimer’s trial rules   

Living with Dementia

pseudogeneral paralysis1 - dementia and down’s syndrome1 - medium spiny neurons1 - tomosyn1 - alzheimer treatment1 - haldol1 - mild alzheimer's disease1 - mitochondria1 - psychomotor retardation1 - abnormal tau protein1 - incident dementia1 - memory capacity1 - effective aging1 - mild tbi1 - risk of alzheimer's3 - cancer1 - cognitive changes1 - slowed movement1 - mood changes1 - experimental alzheimer's drug1 - treatment for alzheimer's1 - phosphodiester1 - earliest stages of alzheimers disease1 - pick's disease2 - huntington’s disease2 - drug addiction1 - oral health1 - apoe43 - perchloroethylene1 - play-up programme1 -